Tel-Aviv Sourasky Medical Center

Site:	Tel-Aviv Sourasky Medical Center
Address:
City:	Tel Aviv
State:
Zip:
Country:	Israel

Phase	Trial	Trial Status	Site Status	Drug	NCT#
2	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)	Recruiting	Active	Belzutifan	NCT04924075
3	A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue)	Active, not recruiting	Not yet activated	QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib	NCT03673501